Khai Pang Leong, Mei Yun Yong, Ee Tzun Koh, Peter Pak Moon Cheung, Manjari Lahiri, Chin Teck Ng, Chia Mun Woo, Liuh Ling Goh, Sandy Hong Hong Lim, Preeti Dhanasekaran, Grace Yee May Cheah, Justina Wei Lyn Tan, Wenchao Hu, Mei Ling Chong, Vikrant Kumar, Sonia Davila
{"title":"Exome Sequencing of Chinese Patients With Anticitrullinated Protein Antibody-Positive Rheumatoid Arthritis in Singapore.","authors":"Khai Pang Leong, Mei Yun Yong, Ee Tzun Koh, Peter Pak Moon Cheung, Manjari Lahiri, Chin Teck Ng, Chia Mun Woo, Liuh Ling Goh, Sandy Hong Hong Lim, Preeti Dhanasekaran, Grace Yee May Cheah, Justina Wei Lyn Tan, Wenchao Hu, Mei Ling Chong, Vikrant Kumar, Sonia Davila","doi":"10.3899/jrheum.2024-0140","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>More than 130 susceptibility loci for rheumatoid arthritis (RA) have been identified with genome-wide association studies. To investigate the genetic predisposition of Chinese patients to anticitrullinated protein antibody (ACPA)-positive RA, we carried out an exome sequencing study.</p><p><strong>Methods: </strong>Patients were recruited from 3 major public hospitals in Singapore: Tan Tock Seng Hospital (TTSH), Singapore General Hospital, and the National University Hospital. Controls came from an established exome collection and from the TTSH Health Control Biobank. All the participants were of Chinese descent. We performed whole-exome sequencing (WES) in 595 ACPA-positive patients with RA and 1281 controls and validated the candidate variants by genotyping 795 RA cases and 600 controls.</p><p><strong>Results: </strong>The discovery cohort yielded 73 susceptibility single-nucleotide variants (SNVs) that reached statistical significance. In the validation study with an independent cohort, 2 SNVs remained significant: <i>PCNXL4</i> (<i>P</i> = 1.50 × 10<sup>-5</sup>) and <i>DHRS7</i> (<i>P</i> = 6.02 × 10<sup>-5</sup>). The majority of known susceptibility foci were not captured by exome sequencing.</p><p><strong>Conclusion: </strong>In this WES study of ACPA-positive RA in Chinese patients, we discovered 2 new variants in <i>PCNXL4</i> and <i>DHRS7</i> associated with risk for RA.</p>","PeriodicalId":50064,"journal":{"name":"Journal of Rheumatology","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3899/jrheum.2024-0140","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: More than 130 susceptibility loci for rheumatoid arthritis (RA) have been identified with genome-wide association studies. To investigate the genetic predisposition of Chinese patients to anticitrullinated protein antibody (ACPA)-positive RA, we carried out an exome sequencing study.
Methods: Patients were recruited from 3 major public hospitals in Singapore: Tan Tock Seng Hospital (TTSH), Singapore General Hospital, and the National University Hospital. Controls came from an established exome collection and from the TTSH Health Control Biobank. All the participants were of Chinese descent. We performed whole-exome sequencing (WES) in 595 ACPA-positive patients with RA and 1281 controls and validated the candidate variants by genotyping 795 RA cases and 600 controls.
Results: The discovery cohort yielded 73 susceptibility single-nucleotide variants (SNVs) that reached statistical significance. In the validation study with an independent cohort, 2 SNVs remained significant: PCNXL4 (P = 1.50 × 10-5) and DHRS7 (P = 6.02 × 10-5). The majority of known susceptibility foci were not captured by exome sequencing.
Conclusion: In this WES study of ACPA-positive RA in Chinese patients, we discovered 2 new variants in PCNXL4 and DHRS7 associated with risk for RA.
期刊介绍:
The Journal of Rheumatology is a monthly international serial edited by Earl D. Silverman. The Journal features research articles on clinical subjects from scientists working in rheumatology and related fields, as well as proceedings of meetings as supplements to regular issues. Highlights of our 41 years serving Rheumatology include: groundbreaking and provocative editorials such as "Inverting the Pyramid," renowned Pediatric Rheumatology, proceedings of OMERACT and the Canadian Rheumatology Association, Cochrane Musculoskeletal Reviews, and supplements on emerging therapies.